menu search

Recursion is granted fda fast track designation for rec-2282 for the potential treatment of nf2-mutated meningiomas

SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technol...

October 7, 2021, 7:55 am

Recursion is granted fda fast track designation for rec-2282 for the potential treatment of nf2-mutated meningiomas

SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technol...

October 7, 2021, 7:55 am

Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...

October 7, 2021, 7:05 am

Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...

October 7, 2021, 7:05 am

Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...

October 7, 2021, 7:05 am

Cue health, google cloud join forces to track respiratory viral variants

Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...

October 6, 2021, 12:33 pm

Cue health, google cloud join forces to track respiratory viral variants

Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...

October 6, 2021, 12:33 pm

Cue health, google cloud join forces to track respiratory viral variants

Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...

October 6, 2021, 12:33 pm

Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test

SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...

October 6, 2021, 10:54 am

Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test

SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...

October 6, 2021, 10:54 am

Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test

SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...

October 6, 2021, 10:54 am

Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform

SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc.  (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...

October 6, 2021, 9:15 am

Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform

SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc.  (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...

October 6, 2021, 9:15 am

Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform

SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc.  (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...

October 6, 2021, 9:15 am

Lexagene to webcast live at virtualinvestorconferences.com october 7th

BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...

October 6, 2021, 8:32 am

Lexagene to webcast live at virtualinvestorconferences.com october 7th

BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...

October 6, 2021, 8:32 am

Lexagene to webcast live at virtualinvestorconferences.com october 7th

BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...

October 6, 2021, 8:32 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...

October 6, 2021, 8:27 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...

October 6, 2021, 8:27 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...

October 6, 2021, 8:27 am


Search within

Pages Search Results: